Chips, Pharma, and a Fed Surprise Dominate

The Big Picture

Markets are navigating a sharp "hawkish shift" in US rate expectations. The FT reports that expectations of a Fed rate rise are triggering reversals in emerging market and commodity currencies. That is the biggest macro development of the day. Risk assets are feeling the pressure. The S&P 500 and Nasdaq closed lower as a chip stock rebound stalled, while South Korean equities dropped more than 5% as AI-linked names sold off hard.

Semiconductors: Both Sides of the Trade

Chips sit at the centre of every major market story today. AMAT executives filed over $80M in stock sales this week. DELL's Silver Lake Group filed nearly $580M in disposals. That is a striking wave of selling near recent highs.

At the same time, bears are circling. Short interest on WOLF exceeds 103% of free float. SOUN has zero borrow availability at 37.5% short interest. Options traders are also building positions around MU's Q3 earnings, due Tuesday.

Pharma Gets a Boost

LLY hit a consensus analyst target above $1,200 — with 22 of 28 analysts rating it a buy. Options activity is picking up around the name.

Europe in Focus

The Bank of England plans to dilute capital rules for investment banks' trading activities. Separately, Reliance Industries is filing for India's largest-ever IPO — the Jio telecoms float. European stocks slid, though the defense sector rallied after Ukraine ratified a $105 billion EU loan deal.

Earnings Week Ahead

FDX, CCL, and MU headline a busy earnings week. Micron is the key name to watch. AI-driven memory demand has lifted expectations. Any miss could hit the broader chip sector hard.